Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in DHR — Danaher Corp /De/

CIK 72971 SAN FRANCISCO, CA
Back to DHR Full portfolio

Position in DHR

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$387,428,638
-$102,047,875 QoQ
Shares Held
2,043,400
-4.4% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.39434276206322.ToString("F0")% Shared 0.ToString("F0")% None 3.605657237936772.ToString("F0")%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$701,520
PutShares
3,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $2,067,077,099 across 37 Diagnostics & Research names. DHR ranks #2 (18.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 1,443,512 $709,529,450
2 DHR
Danaher Corp /De/
This page 		2,043,400 $387,428,638
3 DGX
Quest Diagnostics Inc
 1,762,769 $345,467,465
4 IDXX
Idexx Laboratories Inc /De
 208,847 $117,349,038
5 LH
Labcorp Holdings Inc.
 321,411 $85,755,667
6 NTRA
Natera, Inc.
 409,151 $81,826,106
7 IQV
Iqvia Holdings Inc.
 388,264 $66,214,541
8 WAT
Waters Corp /De/
 207,364 $61,752,996

All Filings in DHR

Export CSV
44 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $701,520 3,700
2026-03-31 $387,428,638 2,043,400
2025-12-31 $847,004 3,700
2025-12-31 $489,476,513 2,138,199
2025-09-30 $793,040 4,000
2025-09-30 $406,526,575 2,050,472
2025-06-30 $790,160 4,000
2025-06-30 $409,163,020 2,071,292
2025-03-31 $411,083,630 2,005,286
2025-03-31 $697,000 3,400
2025-03-31 $492,000 2,400
2024-12-31 $493,699,150 2,150,726
2024-12-31 $826,380 3,600
2024-09-30 $647,642,583 2,329,482
2024-09-30 $667,248 2,400
2024-06-30 $578,296,811 2,314,576
2024-03-31 $544,513,459 2,180,496
2023-12-31 $490,315,643 2,119,459
2023-12-31 $9,484,940 41,000
2023-12-31 $439,546 1,900
2023-09-30 $219,946 1,000
2023-09-30 $417,898 1,900
2023-09-30 $457,112,353 2,078,286
2023-06-30 $470,491,581 2,211,310
2023-06-30 $212,766 1,000
2023-06-30 $1,085,106 5,100
2023-03-31 $535,868,279 2,398,268
2023-03-31 $2,055,645 9,200
2023-03-31 $1,385,326 6,200
2022-12-31 $164,710 700
2022-12-31 $141,180 600
2022-12-31 $579,119,097 2,461,180
2022-09-30 $22,898 100
2022-09-30 $589,901,850 2,576,210
2022-06-30 $601,194,655 2,674,927
2022-03-31 $782,712,538 3,009,920
2021-12-31 $844,073,018 2,893,877
2021-09-30 $909,996,739 3,371,687
2021-06-30 $800,031,349 3,362,779
2021-03-31 $736,074,026 3,688,873
2020-12-31 $759,555,449 3,856,931
2020-09-30 $686,766,052 3,597,604
2020-06-30 $574,663,693 3,665,784
2020-03-31 $438,993,936 3,577,669

Report a Problem

Category
Description
Email (optional, for follow-up)